Allergenix is an Australian-based contract research organisation that specialises in sheep models of pulmonary drug delivery, and pulmonary disease models including asthma, COPD and fibrosis.

Allergenix provides in vivo, in vitro and ex vivo efficacy studies for preclinical validation of new drug targets and evaluation of emerging drug delivery technologies. 

Sheep lungs are very similar to human lungs, and the Allergenix sheep models of allergic asthma, COPD and pulmonary fibrosis represent many features of the human disease condition.

We offer preclinical testing platforms that deliver important mechanistic data informing efficacy study design. In addition to providing the traditional values of reproducibility, efficient timelines and quality reporting, our contract services are characterized by:

• custom study design and data interpretation by experienced team of scientists
• access to world-class research facilities and services